Literature DB >> 7006611

Anti-tetanus toxoid antibody synthesis after booster immunization in systemic lupus erythematosus. Comparison of the in vitro and in vivo responses.

K Nies, R Boyer, R Stevens, J Louie.   

Abstract

The in vivo and in vitro synthesis of anti-tetanus toxoid antibody (anti-tet) was measured after booster immunization with tetanus toxoid in 9 patients with systemic lupus erythematosus (SLE) and 9 controls. In vitro culture of peripheral blood lymphocytes (PBL) from both patients and controls showed maximal anti-tet synthesis 7 days after booster immunization, and maximal serum titers occurred by day 14. The initial in vitro burst of anti-tet synthesis was not dependent upon pokeweed mitogen (PWM) stimulation, whereas later synthesis was PWM dependent. Two differences between patients and controls were observed: 1) patients with SLE had a lower mean pre-boost serum titer of anti-tet, and 2) one-third of the patients showed a blunted serum anti-tet response. To study whether these abnormalities were a result of altered immune regulation, anti-tet synthesis was measured by the coculture of separated SLE-B or control-B cells and separated SLE-T or control-T cell populations (+/- irradiation to remove suppressor T cell activity). These coculture studies showed that both abnormalities were due to a lack of SLE-B cell response, not to abnormalities of SLE-helper T or SLE-suppressor T cell function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7006611     DOI: 10.1002/art.1780231203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus. Chesapeake Pediatric Nephrology Study Group.

Authors:  M M Moxey-Mims; K Preston; B Fivush; F McCurdy
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

2.  Specific suppression of anti-DNA production in vitro.

Authors:  M R Liebling; C Wong; J Radosevich; J S Louie
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

3.  Specific immune responses to skin test antigens following repeated multiple antigen skin tests in normal individuals.

Authors:  B Lesourd; W D Winters
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

4.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

5.  Immune response to influenza vaccine in children with inflammatory bowel disease.

Authors:  Ying Lu; Denise L Jacobson; Lori A Ashworth; Richard J Grand; Anthony L Meyer; Monica M McNeal; Matt C Gregas; Sandra K Burchett; Athos Bousvaros
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

Review 6.  Vaccination of patients with autoimmune inflammatory rheumatic diseases.

Authors:  Johanna Westra; Christien Rondaan; Sander van Assen; Marc Bijl
Journal:  Nat Rev Rheumatol       Date:  2014-12-09       Impact factor: 20.543

7.  B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.

Authors:  C G Kallenberg; P C Limburg; C Van Slochteren; F J Van der Woude; T H The
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

8.  Impaired IgG response to tetanus toxoid in human membranous nephropathy: association with HLA-DR3.

Authors:  J Feehally; P E Brenchley; B M Coupes; N P Mallick; D M Morris; C D Short
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

9.  Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus.

Authors:  O Saiki; Y Saeki; S Kishimoto
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

Review 10.  The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease.

Authors:  Yu Bin Seo; Su Jin Moon; Chan Hong Jeon; Joon Young Song; Yoon Kyoung Sung; Su Jin Jeong; Ki Tae Kwon; Eu Suk Kim; Jae Hoon Kim; Hyoun Ah Kim; Dong Jin Park; Sung Hoon Park; Jin Kyun Park; Joong Kyong Ahn; Ji Seon Oh; Jae Won Yun; Joo Hyun Lee; Hee Young Lee; Min Joo Choi; Won Suk Choi; Young Hwa Choi; Jung Hyun Choi; Jung Yeon Heo; Hee Jin Cheong; Shin Seok Lee
Journal:  Infect Chemother       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.